COMPANY INTELLIGENCE PROFILE

Monitra Healthcare Private Limited

Monitra Healthcare (brand "Monitra Health"), based at T-Hub, Hyderabad, is an Indian medtech/HealthTech company building indigenous cardiac remote-monitoring technology for underdiagnosed heart-rhythm disorders (arrhythmia).

Active (Compliant)Unlisted / Private company — not listedRoC Hyderabad (Telangana) — Tofler names it "Telangana", TheCompanyCheck names it "Hyderabad"; same jurisdiction, minor label difference
AI Overview Generating…

Monitra Healthcare, established on December 1, 2014, is a HealthTech company in Hyderabad focused on cardiac remote-monitoring technology for heart-rhythm disorders. Its flagship product, upBeat, offers hospital-grade ECG monitoring for home use. The company received awards and grants for innovation. Financial data for 2025 shows revenue of ₹5.03 crore, up 89% YoY. A pre-Series A funding of USD 1.5 million was announced in December 2023.

AI-generated, may contain errors.

Business Overview

  • Monitra Healthcare, brand "Monitra Health", based at T-Hub, Hyderabad, is an Indian medtech/HealthTech company building indigenous cardiac remote-monitoring technology for underdiagnosed heart-rhythm disorders (arrhythmia).
  • Its flagship product, upBeat®, is a hospital-grade ambulatory ECG monitoring patch for home use, supporting Holter monitoring (24h+), External Loop Recording (up to 7 days) and Mobile Cardiac Telemetry, real-time 24x7 transmission, with AI-assisted, clinician-reviewed reporting.
  • The company has received recognition including a HYSEA innovation-summit best-product award and BIRAC / US-India Science & Technology grants, source: monitrahealth.com, YourStory July 2025 coverage referenced via search snippet.

Sector & Classification

Business services — manufacture of chemical & chemical products, pharmaceuticals, medicinal chemical and botanical products (registered NIC code); operationally a HealthTech/cardiac-monitoring device and remote-diagnostics company (Tofler + TheCompanyCheck, cross-checked against monitrahealth.com)

Directors & Key Management

Directors — source notes

5 directors on record (Tofler, cross-checked against TheCompanyCheck names — DINs only on Tofler): - Ravi Ramachandra Bhogu — DIN 06983724 — Director/shareholder, since 01 Dec 2014 (founder-era director) - Aparna Bhogu — DIN 06983697 — Director/shareholder, since 01 Dec 2014 (founder-era director) - Kuduva Kuppuraman Venkataraman — DIN 02699919 — Nominee Director, since 07 Jun 2019 - Gautam Rajan — DIN 00060730 — Nominee Director, appointed 26 Dec 2023 (timing coincides with the Dec 2023 pre-Series A close — likely an investor nominee, not confirmed) - Sashank Ramachandran Bhogu — DIN 10429550 — Director, appointed 26 Dec 2023 Confirmed by 2 sources (Tofler + TheCompanyCheck) for names/roles; DINs are Tofler-only (not cross-verified against a second source) so treat DIN accuracy as partial.

GST Registrations

Not obtained. No confirmed GSTIN could be retrieved — knowyourgst.com and findgst.in searches failed to load (500 errors / bot-challenge), and no second source surfaced a specific GSTIN number. PAN AAJCM4998H (from MCA record via Tofler) would underlie any Telangana (state code 36) GSTIN, but the actual registration number, count of state registrations, and status are unconfirmed — do not infer a GSTIN.

Financials

AI Overview Generating…

Monitra Healthcare reported FY2025 standalone revenue of ₹5.03 crore, marking an 89% increase year-on-year (unconfirmed/partial data). In FY2023, revenue was within ₹1-10 crore, with net worth down 43.01% year-on-year and borrowings decreasing by 0.89%.

AI-generated, may contain errors.

  • Two sources disagree on period and only partially disclose figures, flag as unconfirmed/partial:
  • TheCompanyCheck: FY2025, year ended 31 Mar 2025, standalone revenue ₹5.03 crore, +89% YoY
  • EBITDA and PAT locked behind paywall
  • Last AGM 27 Sep 2025
  • Auditor for FY2023 was PSSB & Associates.
  • Tofler: FY2023, year ended 31 Mar 2023, standalone — exact revenue given only as a "₹1–10 crore" band
  • Net worth down 43.01% YoY
  • Total borrowings down 0.89% YoY
  • Exact EBITDA/PAT/net-worth/borrowings figures locked behind Tofler Pro.
  • No net worth or borrowings absolute figures obtained. Standalone basis in both cases, no consolidated financials found.

Funding History

  • Pre-Series A round of USD 1.5 million announced 18 December 2023, reported as led by Equanimity and Kotak, source: news snippet, outlet not independently re-verified — treat as partial/single-source until corroborated on Entrackr/Inc42 directly.
  • No seed round amount/date or subsequent rounds were found.
  • Director timing (Gautam Rajan and Sashank R.
  • Bhogu both appointed 26 Dec 2023) is consistent with, but not proof of, this round closing around that date.

Shareholding

  • Not obtained — shareholding pattern is locked behind premium access on TheCompanyCheck/Tofler and was not found elsewhere. Founder-director shareholders are Ravi Ramachandra Bhogu and Aparna Bhogu, per director listing
  • Nominee directors Kuduva Kuppuraman Venkataraman and Gautam Rajan likely represent institutional/angel investors but the underlying investor entities and stake percentages are unconfirmed.

Loans & Charges

Charge holderAmountDetails
One open charge of₹2 croreregistered 28 October 2024
identity not disclosed in free-tier source. Satisfied charges₹0Source: Thecompanycheck
  • lender recorded generically as "Others", lender single source, not cross-verified

Credit Ratings

  • None found. No CRISIL, ICRA, or CARE rating for Monitra Healthcare Private Limited surfaced in available sources — consistent with a small, early-stage, VC-funded company that would not typically carry a public bank-facility rating.

Competitive Landscape

  • In India's remote cardiac/vital-signs monitoring space: Dozee, Turtle Shell Technologies, — contactless vital-signs/cardiac monitoring, well-funded, larger scale
  • Agatsa (SanketLife) — handheld/wearable ECG devices, similar early-growth scale
  • Nemocare — remote patient monitoring, broader vitals, including maternal/neonatal, comparable early-stage scale.
  • Global/larger-scale reference points for the ambulatory-ECG-patch category: iRhythm Technologies, Zio patch, US, publicly listed, large scale, and BioTelemetry/Philips, ambulatory cardiac monitoring, large scale, — included as category benchmarks rather than direct India-market competitors.

Frequently Asked Questions

What does Monitra Healthcare do?

Monitra Healthcare is an Indian medtech/HealthTech company that develops cardiac remote-monitoring technology for arrhythmia. Their flagship product, upBeat®, is a hospital-grade ambulatory ECG monitoring patch designed for home use, offering features like Holter monitoring, External Loop Recording, and Mobile Cardiac Telemetry with AI-assisted reporting.

What is the incorporation date of Monitra Healthcare?

Monitra Healthcare was incorporated on 01 December 2014.

What is the CIN of Monitra Healthcare?

The Corporate Identification Number (CIN) of Monitra Healthcare is U74900TG2014PTC096612.

What is the GSTIN of Monitra Healthcare?

There is no confirmed GSTIN for Monitra Healthcare. Searches on knowyourgst.com and findgst.in were unsuccessful, and no second source has confirmed a specific GSTIN number.

What is the registered office of Monitra Healthcare?

The registered office of Monitra Healthcare is located at 202 Mani Niketan, Plot 496, Defence Colony, Hyderabad, Telangana, India to 500094.

Sources

Tofler (tofler.in) — identity, capital, directors/DINs, FY2023 financial trend; TheCompanyCheck (thecompanycheck.com) — identity, directors, FY2025 revenue, charges, EPFO headcount; monitrahealth.com — business overview, logo, address confirmation; Bing search snippets (via WebFetch) — funding round detail, competitor names, credit-rating check; Indian Kanoon (indiankanoon.org) — legal search (no results); falconebiz.com and knowyourgst.com/findgst.in attempts failed to return usable data (blocked/500/paywalled homepage).

Information compiled from public registry and secondary sources. It may be incomplete or dated; verify independently before relying on it.